查詢結果分析
相關文獻
- Minimally Invasive Surgery for Localized Prostate Cancer
- 攝護腺癌的低侵襲性治療
- 達文西機械手臂輔助大腸直腸手術之現況
- Robotic-Assisted Laparoscopic Rectal Surgery: A Tertiary Center Experience
- 比較傳統開腹手術、腹腔鏡手術以及達文西機械手臂手術治療胃癌的手術成果
- 胰臟體尾部切除手術方式:達文西機械手臂手術、腹腔鏡手術、傳統剖腹手術之比較
- 達文西立體機械手臂腹腔鏡手術
- 微創手術在一般外科的新進展
- 新型醫療技術之擴展--腹腔鏡相關手術為例
- 根除性攝護腺切除術治療攝護腺癌腹腔鏡或剖腹手術?
頁籤選單縮合
題 名 | Minimally Invasive Surgery for Localized Prostate Cancer=局限性攝護腺癌之微創手術治療 |
---|---|
作 者 | 歐宴泉; 王約翰; 熊小澐; 楊晨洸; 程千里; 楊啟瑞; | 書刊名 | 臺灣癌症醫學雜誌 |
卷 期 | 26:4 2010.08[民99.08] |
頁 次 | 頁145-154 |
分類號 | 416.275 |
關鍵詞 | 腹腔鏡; 攝護腺癌; 攝護腺根除術; 機械手臂; Laparoscopy; Prostate cancer; Radical prostatectomy; Robotics; |
語 文 | 英文(English) |
中文摘要 | 攝護腺癌在歐美是最常被診斷的惡性腫瘤。雖然在台灣攝護腺癌的發生率不高,但 近20 年逐漸升高。局線性攝護腺癌之微創手術包括:腹腔鏡及機械手臂根除性攝護腺切 除,在本院接受根除性攝護腺切除術之病患,約有70% 採用機械手臂切除攝護腺,機械手臂根除性攝護腺切除術有潛力成為治療局限性攝護腺癌的主流方式。腹腔鏡攝護腺切 除術之術後12 個月禁尿控制率達66% - 95%,12 個月及18 個月性功能恢復達42%及 76%,機械手臂根除性攝護腺切除有較好的禁尿率 84% - 97%,性功能恢復達70%-80% 手術邊緣腫瘤陽性率在腹腔鏡手術為11% - 30%,機械手臂為9.6% - 26%,從單一手術醫 師擔270 例的經驗,顯示良好的禁尿率及可接受的性功能恢復率,對於腫瘤控制降低手 術邊緣陽性率,仍有很大的改善空間。 |
英文摘要 | Prostate cancer is the most commonly diagnosed solid tumor cancer in both Europe and the US. Although there were previously low incidence and mortality rates of prostate cancer in Taiwan, these rates have risen rapidly in the past two decades. Options for minimally invasive surgical treatment of localized prostate cancer include laparoscopic radical prostatectomy (LRP), and robotic-assisted laparoscopic radical prostatectomy (RALP). Trends in treatment for localized prostate cancer after emergence of robotic-assisted laparoscopic radical prostatectomy were obvious. The percentage of RALP in patients with localized prostate cancer receiving radical prostatectomy is now about 70% in this institute. There is potential of robotic-assisted prostatectomy to become the mainstream treatment for localized prostate cancer in Taiwan. Twelve-month continence rates ranged from 66% to 95% after LRP. In terms of erectile function recovery, the 12- and 18-mo potency rates reported in noncomparative studies ranged from 42% to 76% after LRP. Better functional results were suggested following RALP. Excellent functional outcomes were reported in several large series from referral centers with high volume of RALP, showing continence rates ranging from 84% to 97% and potency rates from 70% to 80%. The positive surgical margin (PSM) rate was from 11% to 30% after LRP, and from 9.6% to 26% after RALP. Experience with 270 cases of RALP performed by single surgeon showed excellent continence rate and acceptable potency rate. There is still much room to improve cancer control by reducing the positive surgical margin rate. |
本系統中英文摘要資訊取自各篇刊載內容。